212 related articles for article (PubMed ID: 21136030)
21. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
[TBL] [Abstract][Full Text] [Related]
22. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
23. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
[TBL] [Abstract][Full Text] [Related]
24. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.
Bhide SA; Davies M; Burke K; McNair HA; Hansen V; Barbachano Y; El-Hariry IA; Newbold K; Harrington KJ; Nutting CM
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1360-8. PubMed ID: 20338474
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal changes over 2 years in parotid glands of patients treated with preoperative 30-Gy irradiation for oral cancer.
Tomitaka E; Murakami R; Teshima K; Nomura T; Nakaguchi Y; Nakayama H; Kitajima M; Hirai T; Araki Y; Shinohara M; Yamashita Y
Jpn J Clin Oncol; 2011 Apr; 41(4):503-7. PubMed ID: 21233103
[TBL] [Abstract][Full Text] [Related]
26. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
27. Metabolic imaging biomarkers of postradiotherapy xerostomia.
Cannon B; Schwartz DL; Dong L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
[TBL] [Abstract][Full Text] [Related]
28. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
29. Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.
Hey J; Setz J; Gerlach R; Janich M; Hildebrandt G; Vordermark D; Gernhardt CR; Kuhnt T
Radiat Oncol; 2011 Sep; 6():125. PubMed ID: 21951317
[TBL] [Abstract][Full Text] [Related]
30. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
[TBL] [Abstract][Full Text] [Related]
31. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.
Owosho AA; Thor M; Oh JH; Riaz N; Tsai CJ; Rosenberg H; Varthis S; Yom SH; Huryn JM; Lee NY; Deasy JO; Estilo CL
J Craniomaxillofac Surg; 2017 Apr; 45(4):595-600. PubMed ID: 28256385
[TBL] [Abstract][Full Text] [Related]
32. Parotid gland shrinkage during IMRT predicts the time to Xerostomia resolution.
Sanguineti G; Ricchetti F; Wu B; McNutt T; Fiorino C
Radiat Oncol; 2015 Jan; 10():19. PubMed ID: 25595326
[TBL] [Abstract][Full Text] [Related]
33. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
[TBL] [Abstract][Full Text] [Related]
34. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
[TBL] [Abstract][Full Text] [Related]
35. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
Li Y; Taylor JM; Ten Haken RK; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
[TBL] [Abstract][Full Text] [Related]
36. Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer.
Gjini M; Ahmed S; Kalnicki S; Tomé WA; Garg MK; Kabarriti R; Brodin NP
Acta Oncol; 2022 Sep; 61(9):1069-1074. PubMed ID: 35978529
[TBL] [Abstract][Full Text] [Related]
37. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
39. Level II lymph nodes and radiation-induced xerostomia.
Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
[TBL] [Abstract][Full Text] [Related]
40. Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy.
van Luijk P; Faber H; Schippers JM; Brandenburg S; Langendijk JA; Meertens H; Coppes RP
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1002-5. PubMed ID: 19545785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
